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Wide Variation and Rising Utilization of
Stroke Magnetic Resonance Imaging:
Data from 11 States
James F. Burke, MD,1,2,3 Kevin A. Kerber, MD,3 Theodore J. Iwashyna, MD, PhD,1,4
and Lewis B. Morgenstern, MD3,5
Objective: Neuroimaging is an essential component of the acute stroke evaluation. Magnetic resonance imaging
(MRI) is more accurate than computed tomography (CT) for the diagnosis of stroke, but is more costly and time-
consuming. We sought to describe changes in MRI utilization from 1999 to 2008.
Methods: We performed a serial cross-sectional study with time trends of neuroimaging in patients with a primary
International Classification of Diseases, 9th Edition, Clinical Modification discharge diagnosis of stroke admitted
through the emergency department in the State Inpatient Databases from 10 states. MRI utilization was measured
by Healthcare Cost and Utilization Project criteria. Data were included for states from 1999 to 2008 where MRI
utilization could be identified.
Results: A total of 624,842 patients were hospitalized for stroke in the period of interest. MRI utilization increased in all
states. Overall, MRI absolute utilization increased 38%, and relative utilization increased 235% (28% of strokes in 1999
to 66% in 2008). Over the same interval, CT utilization changed little (92% in 1999 to 95% in 2008). MRI use varied
widely by state. In 2008, MRI utilization ranged from a low of 55% of strokes in Oregon to a high of 79% in Arizona.
Diagnostic imaging was the fastest growing component of total hospital costs (213% increase from 1999 to 2007).
Interpretation: MRI utilization during stroke hospitalization increased substantially, with wide geographic variation.
Rather than replacing CT, MRI is supplementing it. Consequently, neuroimaging has been the fastest growing
component of hospitalization cost in stroke. Recent neuroimaging practices in stroke are not standardized and may
represent an opportunity to improve the efficiency of stroke care.
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Neuroimaging is an essential component of acutestroke evaluation. Although magnetic resonance
imaging (MRI) has several clear advantages compared to
computed tomography (CT) in stroke diagnosis, its role in
acute stroke management has yet to be completely eluci-
dated. Compared to CT, MRI is a more accurate test for
acute ischemia1–5 and comparably accurate for the detec-
tion of intracerebral hemorrhage.6 Additional advantages
of MRI include the improved ability to detect subtle hem-
orrhagic changes,7,8 to identify stroke location,9 and in
some cases to clarify stroke mechanism.10–12
Despite these advantages, downsides to MRI do
exist. These include longer scan times and higher costs
per scan compared to CT. In addition, there are few data
demonstrating that MRI findings lead to changes in
patient management versus CT alone.13 Further, no data
yet demonstrate improved outcomes in stroke patients
undergoing MRI compared with stroke patients who do
not undergo MRI.
In this study, we sought to describe trends in MRI
use over the 10-year period of 1999 to 2008 as a means
of determining its changing role in routine stroke care
and to assess for opportunities to optimize its use. We
hypothesized that MRI utilization would increase con-
cordant with overall trends in diagnostic imaging utiliza-
tion.14 We further hypothesized that geographic variation
in MRI utilization would exist because evidence-based
guidelines did not preferentially recommend CT or MRI
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for stroke evaluation.15–17 Finally, given prominent
societal concerns about health care costs, we sought to
characterize costs of MRI and diagnostic imaging during
stroke hospitalization. Understanding these trends is
essential to the development and implementation of
standardized and efficient neuroimaging strategies in
stroke.
Patients and Methods
Dataset and Study Population
We examined all patients with a discharge diagnosis of stroke
in a select group of states from 1999 through 2008. States were
chosen to incorporate geographic, temporal, and racial variabili-
ty within the constraints of data availability, consistent partici-
pation in State Inpatient Databases (SID), data cost, and the
ability to identify MRIs. Our specific study population
consisted of discharge data from Washington (1999–2008),
New York (1999–2008), Arizona (1999–2008), Florida (1999–
2005), Nebraska (2004–2008), Massachusetts (2004–2008),
North Carolina (2004–2008), Iowa (2008), Wisconsin (2008),
New Jersey (2008), and Oregon (2008).
This study analyzed hospital discharges from SID devel-
oped as part of the Healthcare Cost and Utilization Project
(HCUP), funded by the Agency for Healthcare Research and
Quality.18 SID consists of abstracts for all acute care discharges
within a state for a given year. Discharge abstracts consist of
basic demographics, payer information, hospitalization charac-
teristics, charges, primary diagnoses, and procedural utilization.
We included all discharges for subjects >18 years of age
in whom the primary discharge diagnosis was ischemic stroke
by International Classification of Diseases, 9th Edition, Clinical
Modification (ICD-9-CM; 433.x1, 434.x1, 436)19 admitted
through the emergency department. This approach has been
previously validated and found to have a positive predictive
value of 88% and sensitivity of 74%.20
The University of Michigan Institutional Review Board
determined this study to be exempt from formal review as it
relied on publicly available data.
Categorizing Comorbidities
To understand how patient-level variables may influence which
patients undergo MRI, we characterized secondary diagnoses in
our population of stroke patients. Vascular risk factor and
potential stroke mimic diagnoses were characterized using
HCUP single-level Clinical Classification System (CSS)21
definitions: hypertension (CCS 98, 99), diabetes (CCS 49, 50),
hyperlipidemia (CCS 53), epilepsy (CCS 83), migraine (CCS
84). A stroke modified Charlson comorbidity index was created
for each patient using previously described methods.22,23
Measuring Neuroimaging Exposure
We measured MRI and CT utilization using the criteria for
HCUP’s Magnetic Resonance Technology Utilization and CT
Scan flags, respectively.24 These flags define whether a patient
underwent any CT or MRI imaging study during their hospital-
ization and are primarily defined by Uniform Billing (UB-92)
revenue codes. UB-92 revenue codes are standardized codes
that are automatically generated by hospital billing systems and
reflect charges from specific revenue centers.25 HCUP has inter-
nally validated revenue codes for the identification of specific
utilization groups, including MRI and CT.26 This approach
was used instead of a less reliable identification strategy relying
onICD-9-CM procedure code alone, because ICD-9-CM strat-
egies are unreliable for procedures that do not change Diagno-
sis-Related Group (DRG) assignment,25 and stroke DRGs are
not impacted by whether patients undergo neuroimaging.
Statistical Analysis
To summarize the characteristics of the population, demo-
graphic information, stroke risk factors, and neuroimaging utili-
zation were reported with percentages or means and standard
deviations (SDs). Comparisons between those receiving MRI
and not receiving MRI were made using t tests and chi-square
tests for continuous and categorical variables, respectively. To
describe trends in neuroimaging utilization, we divided the
number of patients receiving a neuroimaging study by the total
number of stroke cases identified, stratifying by state and year.
Significance of trends was assessed using 1-sample t tests of
change in imaging utilization per year to evaluate the null
hypothesis that no change in utilization occurred. To account
for imbalance in potentially relevant variables, adjusted esti-
mates of MRI utilization by state and over time were generated
using multivariate logistic regression accounting for clustering
at the hospital level. In both analyses, we adjusted for age, gen-
der, vascular risk factors (hypertension, diabetes, hyperlipidemia,
atrial fibrillation), Charlson comorbidity index, and insurance
status (Medicare vs Medicaid vs private insurance vs other in-
surance). Results were reported as mean posterior probabilities,
with covariates set at population means.
To estimate the availability of MRI and impact of MRI
availability on utilization, hospital-level MRI utilization patterns
were analyzed. To minimize the impact of miscoded data, a
hospital was defined as having established MRI access if 3 or
more stroke patients received MRIs at that facility in a given
year. This definition will likely underestimate actual MRI
access, as some hospitals may have the capacity to obtain MRIs
and not opt to use that capacity. We then calculated the annual
proportion of stroke patients presenting to hospitals with estab-
lished MRI access.
Next, we sought to quantify geographic variation at the
state and hospital referral region (HRR) levels by calculating
aggregate MRI utilization rates at both levels by year. HRRs
represent discrete geographic regions defined by regional referral
patterns for tertiary medical care defined by the presence of at
least 1 hospital that performs major cardiovascular and neuro-
surgical procedures.27–29 To measure annual utilization, we
aggregated patient-level records at the HRR level, calculated
utilization over HRR, ranked the HRRs by utilization rate, and
then calculated utilization by HRR quintile.
Finally, we estimated inflation-adjusted costs for the total
hospitalization, UB-92 cost categories, MRI, and CT. Total
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hospital charges were abstracted directly from the SID discharge
record. All charges within a given UB-92 cost center, identified
by revenue code, were summed to derive charges per cost cen-
ter. MRI and CT costs were calculated by summing costs asso-
ciated with UB-92 revenue codes 610-619 and 0350-0359,
respectively. This approach combines all CT- and MRI-related
costs into single categories and consequently is not able to dis-
tinguish between the costs of repeat imaging studies and of
combined imaging studies such as multimodal imaging. To
account for local variation in charges, HCUP cost-to-charge
ratios were applied to hospital charges to estimate hospital
costs.30 As a consequence, we were able to estimate actual costs
of care as opposed to the amount charged for care. Because we
were interested in overall expenditure trends, costs were infla-
tion-adjusted to 2008 dollars using the gross domestic product
price index.31 For clarity of reporting, state data were aggre-
gated into 2 separate time cohorts based on the availability of
longitudinal data. Cohort 1 consists of data from New York,
Florida, Arizona, and Washington from 1999 to 2007, and
cohort 2 consists of data from New York, Arizona, Washington,
North Carolina, and Massachusetts from 2004 to 2008. We
report costs for the 5 largest cost centers. All costs were sum-
marized as means and standard deviations. All data analyses
were performed with Stata version 11.1 (Stata Corp, College
Station, TX).
Results
Study Population
Over the 10-year study period (1999–2008), 624,842
primary ischemic stroke hospitalizations were identified
(Table 1). Mean age was 73 6 14 years, and 54% were
female. Cardiovascular risk factors were common. Most
patients (70%) were insured by Medicare.
MRI was performed in 50% of the total population
and CT in 95%. On average, patients who underwent
MRI were younger (70 years vs 76 years, p < 0.001),
more likely to have private insurance (22% vs 15%, p <
0.001), and had a greater burden of vascular risk factors
compared with patients who did not undergo MRI. A
history of atrial fibrillation was less common in patients
who had an MRI (27% vs. 16%, p < 0.001).
Temporal Trends in Diagnostic imaging
From 1999 to 2008, absolute MRI utilization increased
38%, a relative increase of 235% (28% in 1999 to 66%
in 2008, p ¼ 0.003 for trend, Fig 1). Of patients receiv-
ing an MRI, 95% also received a CT. Overall CT utiliza-
tion did not change during the same interval (92% in
1999 to 95% in 2008, p ¼ 0.34 for trend). After
TABLE 1: Study Population Baseline Characteristics
Demographics MRI, n ¼ 310,768 No MRI, n ¼ 314,074 All Subjects, n ¼ 624,842
Age, mean yr (SD) 70 (14) 76 (13) 73 (14)
Female 52% 57% 54%
Race/ethnicity
White 60% 61% 61%
Black 7% 7% 7%
Hispanic 14% 12% 13%
Insurance
Medicare 64% 75% 70%
Medicaid 8% 6% 7%
Private insurance 22% 14% 18%
Other insurance 6% 4% 5%
Comorbidities
Hypertension 72% 67% 69%
Hyperlipidemia 32% 19% 25%
Diabetes 30% 28% 29%
Coronary artery disease 21% 27% 24%
Atrial fibrillation 16% 27% 21%
Modified Charlson, mean (SD) 3.8 (2) 4.5 (1.9) 4.1 (1.9)
MRI ¼ magnetic resonance imaging; SD ¼ standard deviation.
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adjusting for the changing age, sex, vascular risk factors,
comorbidities, and insurance status of the population,
each year was associated with a 4.0% increase the proba-
bility of receiving MRI in the logistic regression model
(odds ratio, 1.20; 95% CI, 1.18–1.22).
Regional Variation in Diagnostic Imaging
Utilization of MRI by state is illustrated in Figure 2 for
2008, the year for which the broadest cross section of
data was available. In 2008, MRI utilization ranged from
a low of 55% in Oregon to a high of 79% in Arizona.
Adjustment for age, sex, vascular risk factors, comorbid-
ities, and insurance status had minimal impact on the
pattern of variation by state. More extreme geographic
variation is seen when analyzing MRI utilization by
HRR quintile (Table 2). In every year, MRI utilization
rates were at least 30% higher in the highest utilizing
quintile compared to the lowest utilizing quintile.
Established Access to MRI
There was a modest overall increase in the number of
hospitals with established MRI access; 74% of hospitals
had access in 1999 versus 87% in 2008 (p < 0.01; Table
3). The hospitals that gained MRI access over time were
mostly lower volume centers, consequently there was less
change in the percentage of stroke patients presenting to
hospitals with MRI access: 89% in 1999 versus 96% in
2008 (p < 0.01). This suggests that physician practice
regarding MRI is more important than the availability of
MRI scanners per se to explain the rising rates of MRI
utilization.
Cost Trends
Mean hospital costs increased from $9,058 (SD,
$11,867) to $12,842 (SD, $15,551) in the group of
states with the most complete cost data (New York, Flor-
ida, Arizona, and Washington from 1997 to 2007).
Diagnostic imaging (radiotherapy, CT, MRI, nuclear
FIGURE 1: Utilization trends in diagnostic imaging for
stroke. CT 5 computed tomography; MRI 5 magnetic reso-
nance imaging.
FIGURE 2: Percentage of stroke patients receiving mag-
netic resonance imaging (MRI), 2008. Blue bars represent
unadjusted utilization by state. Red bars represent utiliza-
tion adjusted for age, sex, vascular risk factors, comorbid-
ities, and insurance status.
TABLE 2: MRI Utilization Quintiles by Year,
Defined by HRR
Year Percentage Receiving MRI by
HRR Utilization Quintile
1 (lowest
users)
2 3 4 5 (highest
users)
1999 7% 17% 23% 29% 39%
2000 10% 21% 27% 35% 50%
2001 17% 28% 35% 42% 55%
2002 22% 31% 41% 51% 63%
2003 23% 36% 45% 57% 66%
2004 31% 45% 51% 64% 72%
2005 34% 47% 55% 66% 74%
2006 34% 52% 55% 62% 77%
2007 36% 55% 60% 66% 77%
2008 43% 58% 64% 70% 78%
HRR ¼ hospital referral region; MRI ¼ magnetic resonance
imaging.
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medicine, ultrasound, electrocardiography, and electroen-
cephalography) was the second largest cost center over
this interval behind only room and board charges, and
underwent the largest percentage increase (213%; Fig 3).
MRI costs increased faster than overall diagnostic imag-
ing costs, increasing 413% from 1999 to 2007, from 3%
of total hospital costs in 1999 to 9% in 2007. CT costs
increased by 171% from 6% of total costs in 1999 to
8% in 2007. Similar trends were seen in the group of
states with adequate cost data only in the later period
(New York, Arizona, Washington, North Carolina, and
Massachusetts from 2004 to 2008); diagnostic imaging
was the second largest cost component and underwent
the largest percentage increase (129%), with MRI
(138%) and CT costs (133%) increasing slightly faster.
In 2008, MRI costs accounted for 10% of total hospital
costs and CT for 8%.
Discussion
MRI utilization in ischemic stroke has increased substan-
tially from 1999 to 2008. Growth in MRI utilization
was seen in every year in every state in our study popula-
tion. In high-utilizing regions, the rate has plateaued at a
level suggesting that nearly all eligible patients are receiv-
ing MRI.32,33 However, 95% of patients receiving MRI
also received CT. MRI is not replacing CT as the
primary stroke neuroimaging study; instead, receipt of
multiple neuroimaging studies is increasingly common.
In addition to an increase in overall MRI utilization, we
also observed marked geographic variation. In 2008,
55% of stroke patients underwent MRI in Oregon com-
pared to 79% in Arizona. Partly as a consequence of this
widespread increased use, diagnostic imaging has been
the fastest growing cost component of stroke care. These
data suggest that neuroimaging practices in stroke are
neither standardized nor efficient.
The wide geographic variation in MRI utilization
demonstrates a potential opportunity to improve stroke
care by increasing standardization. This variation was not
accounted for by measurable patient characteristics or
hospital acquisition of MRI technology. Although we
cannot directly measure patient preferences, there is little
evidence that patients have strong and variable preferen-
ces among imaging modalities, independent of the advice
of their physicians34; it is further unclear why those pref-
erences would be so geographically variable as to explain
the observed pattern. Absent a credible alternative expla-
nation, variation in physician practice patterns likely
accounts for much of the variation in MRI utilization.
The existence of variation in physician practice in
this context is not surprising, as variation tends be greater
when the evidence for a practice is less certain,29 and
stroke imaging guidelines during the study period did
not preferentially recommend CT or MRI.15,17 Recent
guidelines have generally made more favorable recom-
mendations regarding MRI than previous guidelines, but
TABLE 3: Hospital Availability of MRI
Year Percentage of
Hospitals with
MRI Access
Percentage of
Stroke Patients
at Hospital with
MRI Access
1999 74% 89%
2000 77% 91%
2001 80% 93%
2002 83% 94%
2003 82% 94%
2004 83% 94%
2005 86% 95%
2006 83% 94%
2007 84% 94%
2008 87% 96%
MRI ¼ magnetic resonance imaging.
FIGURE 3: Trends in stroke cost components. (A) Trends in
cost components from 1999 to 2007 in New York, Florida,
Arizona, and Washington. (B) Trends in cost components
from 2004 to 2008 in New York, Arizona, Washington,
North Carolina, and Massachusetts. ICU 5 intensive care
unit.
Burke et al: MRI Utilization in Stroke
February 2012 183
inconsistency between these guidelines exists. Recently,
an American Heart Association scientific statement was
the first major guideline to recommend routine use of
MRI or CT angiography for stroke patients.35 The recent
American Academy of Neurology guideline on the role
of MRI in stroke36 limits its preferential recommenda-
tion of MRI to the period within 12 hours of stroke
onset. The most recent European Stroke Organization
guideline37 calls for stroke patients to receive either CT
or MRI. Standardization of neuroimaging practices may
improve as guidelines become more consistent, particu-
larly if evidence emerges that MRI leads to improved
outcomes or more optimal physician decision making.
The current highly variable use of MRI suggests that
there may be community equipoise that would make a
randomized trial ethical, feasible, and useful.
Not only are stroke neuroimaging practices not
standardized, but our findings suggest stroke neuroimag-
ing may be unnecessarily costly. In our sample, 95% of
patients receiving a MRI also received a CT; thus, mini-
mizing the use of multiple imaging studies may represent
a viable strategy to contain neuroimaging costs. If the
practice of obtaining both MRI and CT reflects physician
preference for MRI in a context where CT can be
obtained more quickly, then several broad strategies for
increasing efficiency are possible. First, some patients
may be able to safely wait for an imaging study, allowing
MRI to be performed without a preceding CT. Patients
with delayed presentations who are out of the acute treat-
ment window and have stable examinations might meet
these criteria and represent a significant proportion of all
stroke patients. Up to 36% of stroke patients present
>12 hours after onset.38 Second, wider dissemination of
rapid stroke MRI protocols relying on a selective set of
sequences (ie, diffusion-weighted, gradient-echo, and
T2-weighted sequences) may minimize resource utiliza-
tion and allow for quicker scanner turnover, thus ena-
bling earlier MRI acquisition.39 For MRI to be a viable
alternative to CT in the acute stroke period, scan times
for MRI must not be greater than CT to minimize time
delay for thrombolysis.
This study has several important limitations. First,
the use of administrative data to identify stroke is an
imprecise process, raising the possibility that some of the
variability in MRI utilization and cost may be due to
imprecision in coding of stroke diagnoses. To minimize
this, we have used a previously validated algorithm to
identify stroke cases.19 Similarly, revenue code-based
identification of imaging studies is also limited by the
inability to reliably identify the subcomponents of an
imaging study, the number of times an individual patient
received a given neuroimaging study, which body part
was imaged, and the timing of imaging studies. Conse-
quently, we are unable to reliably determine the role of
magnetic resonance angiography compared to MRI,
which portion of studies were focused on the central
nervous system, or when imaging studies were obtained
during the hospitalization. Because of this limited infor-
mation, we cannot speculate as to why physicians
obtained an MRI in an individual case (ie, was MRI
obtained to aid thrombolysis decision making, clarify
diagnosis, or inform secondary prevention strategies?).
Additionally, although our dataset was selected to maxi-
mize geographic and demographic variability, the Southern
states and African Americans are underrepresented.
The use of MRI in ischemic stroke has substantially
increased over the past decade, with wide geographic var-
iation and increasing contribution to the cost of stroke
care. These findings emphasize the importance of future
research to define which stroke patients are likely to ben-
efit from MRI, how MRI information should be applied
to individuals, and the relationship between MRI and
clinically meaningful outcomes. Finally, these findings
illustrate the potential to reduce variability and improve
the efficiency of neuroimaging in stroke.
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